Large-scale testing (Phase 3)Ended earlyNCT04537806
What this trial is testing
Brexanolone for Acute Respiratory Distress Syndrome (ARDS) Due to Coronavirus Disease 2019 (COVID-19)
Who this might be right for
Acute Respiratory Distress SyndromeCOVID-19
Sage Therapeutics 29